Home NDC 55146-005 5 Chronic Stress
Product NDC 55146-005
11-digit product format 551460005
Labeler code 55146
Product ID 55146-005_6a145dd9-7f5c-47e5-a854-4a486826a6e2
Type HUMAN OTC DRUG
Nonproprietary name Aralia Quinquefolia, Fucus Vesiculosus, Solidago Virgaurea, Taraxacum Officinale, Trifolium Pratense, Hydrastis Canadensis, Arsenicum Album, Calcarea Carbonica, Carbo Vegetabilis, Ceanothus Americanus, Cyclamen Europaeum, Hepar Sulphuris Calcareum, Natrum Muriaticum, Nux Vomica, Petroleum, Phosphorus
Dosage form LIQUID
Route ORAL
Labeler Biotics Research Corporation
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2019-06-11
Marketing end 0000-00-00
Substance AMERICAN GINSENG; FUCUS VESICULOSUS; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; GOLDENSEAL; ARSENIC TRIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; ACTIVATED CHARCOAL; CEANOTHUS AMERICANUS LEAF; CYCLAMEN PURPURASCENS TUBER; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; KEROSENE; PHOSPHORUS
Active strength 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 20 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 55146-005-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 55146-005-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 55146-005-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 55146-005-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 55146-005-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 55146-005-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 55146-005-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 55146-005-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 55146-005-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 55146-005-01 I Inactivated by FDA bd6a592717d7…303034d00443…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55146-005 5 CHRONIC STRESS (ARALIA QUINQUEFOLIA, FUCUS VESICULOSUS, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, HYDRASTIS CANADENSIS, ARSENICUM ALBUM, CALCAREA CARBONICA, CARBO VEGETABILIS, CEANOTHUS AMERICANUS, CYCLAMEN EUROPAEUM, HEPAR SULPHURIS CALCAREUM, NATRUM MURIATICUM, NUX VOMICA, PETROLEUM, PHOSPHORUS) LIQUID [BIOTICS RESEARCH CORPORATION] 6 Legacy NDC 20241020_6f79905b-767b-49d0-8630-7b5348f87e4d.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 55146-005-01 55146000501 120 mL in 1 BOTTLE, PLASTIC (55146-005-01) 120 ml 2019-06-11 0000-00-00 No No Current